American Thoracic Society Accepting Applications for Grants, Mesothelioma Researchers May Apply
The deadline to apply for research grants from the American Thoracic Society (ATS) is March 15, 2011. Researchers can apply for unrestricted grant support or specific partnership grants for research in targeted areas, as well as for a 2011 MECOR Research Award which provides small seed funds to the graduates of the ATS MECOR program. Researchers hoping to improve treatment options for lung-related diseases, including respiratory conditions such as malignant mesothelioma, asthma, COPD and lung cancer, are urged to apply.
Science and research are among the core values of the ATS, and by funding key research projects towards finding new treatments and cures for respiratory illnesses, they aim to save and improve the quality of lives. The ATS states that lung-related diseases are the third-leading cause of deaths worldwide, and their goal is to advance the clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.
Pleural mesothelioma is a rare form of pulmonary cancer caused by exposure to airborne asbestos fibers. Often called “asbestos cancer,” mesothelioma is highly aggressive and is resistant to many standard cancer treatments. Approximately 3,000 people are diagnosed with the deadly disease in the United States each year. Although there is no cure for mesothelioma, new research and an increased knowledge among medical professionals has increased the survival time and improved the quality of life for many patients.
In their book, “2010 Breathing in America: Diseases, Progress, and Hope,” ATS states “since the use of asbestos has been banned in the United States only since the 1990s, the peak of disease incidence may lie ahead.” Mesothelioma is known for its long latency period which can be as long as 50 years, and once diagnosed the average survival time for mesothelioma patients varies from 4 – 18 months.
All of the applications submitted to the ATS Research Program are reviewed by the ATS Scientific Advisory Committee (SAC), as well as by other experts who provide input in specific areas. Grants are typically $50,000 per year for two years. Since its inception in 2002, ATS research support has grown from approximately $100,000 to over $1.5 million per year.
See the American Thoracic Society for more information.